Hall 6 (Salle E&F, Floor 3)

08:00 - 09:00 BUSINESS MEETING
11:00 - 11:30 BREAK
11:30 - 13:00

Genetics, Basic Science and Myocardial Disease
Chair: Nicole Sekarski, Switzerland
Co-chair: Ingegerd Ostman-Smith, Sweden

O-001 Defining Genotype-Phenotype Correlation in Paediatric Patients With Hypertrophic Cardiomyopathy,
María López Blázquez, Spain
O-002 Shaping the heart tube by modulation of cardiomyocyte differentiation: identification of Greb1l as a genetic determinant of criss-cross heart in mice,
Segolene Bernheim, France
O-003 Pathophysiological Role of Dexmedetomidine for Monocrotaline-induced Pulmonary Arterial Hypertension in Rats,
Yohei Yamaguchi, Japan
O-004 Identifying new genetic causes of pediatric cardiomyopathy by exome sequencing and zebrafish modeling,
Claudine W. B. Ruijmbeek, Netherlands
O-005 Genetic testing outcomes in a cohort of 21,159 children with heart disease,
Flavia Facio, United States
O-006 Platelet adhesion, fibrin deposition and neo-endothelialization in bovine jugular vein conduits and homografts after implantation in sheep,
Ruth Heying, Belgium

14:30 - 16:00

Interventional cardiology
Chair: Oliver Kretschmar, Switzerland
Co-chair: Gianfranco Butera, Italy

O-013 Piggyback Mounting for Stent and Valve Deployment during percutaneous pulmonary valve implantation,
Gareth John Morgan, United States
O-014 Echocardiographically guided interventional PDA closure on the NICU in prematures – initial experience on 22 patients,
Stanimir Georgiev, Germany
O-015 Embolization of Vascular Abnormalities in Children with Congenital Heart Diseases Using Medtronic Micro Vascular Plugs,
Raymond N. Haddad, France
O-016 Transcatheter Occlusion of PDA in Extremely Premature Infants Weighting Less Than 1200 g: A Single-Center Experience With the Micro Vascular Plug,
Matthew Boucek, United States
O-017 Assessment of computer-simulated stent implantation and virtual reality as tools to plan interventional treatment of aortic coarctation,
Nikola Topuzov, Poland
O-018 First Experiences with Myval Transcatheter Heart Valve System in Conduit Dysfunction and Native RVOT with Severe Pulmonary Regurgitation,
Ender Ödemiş, Turkey

16:00 - 16:30 BREAK
16:30 - 18:00

Adult congenital heart disease
Chair: Judith Bouchardy, Switzerland
Co-chair: Paolo Ferrero, Italy

Pulmonary Hypertension in Adults with Congenital Heart Disease: Updated and Extended Results from the International COMPERA-CHD Registry,
Ann Sophie Kaemmerer, Germany
Neuropsychological and Structural Brain Abnormalities in Adults with d-Transposition of the Great Arteries: The Boston Circulatory Arrest Study,
Johanna Calderon, France
Ebstein’s anomaly: Functional outcomes after Cone Reconstruction,
Lina Hock, Germany
The burden of late thrombo-embolic complications following Fontan palliation among polish adolescent patients – multicenter study,
Maciej Skubera, Poland
Long-term Results in Patients with Repaired Tetralogy of Fallot: Up to 38-Year Follow-up of 814 Patients,
Petr Bukovský, Czech Republic
Medical Rehabilitation in Adults with Congenital Heart Disease,
Sebastian Freilinger, Germany